Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the investment in XPartners
Mandate

Vinge advises Axcel in connection with the investment in XPartners

May 03, 2023 M&A Real Estate and Construction Data protection and processing of personal data Corporate Crime & Compliance Employment and Benefits EU, Competition and Regulatory

Vinge has advised Axcel in connection with the investment in XPartners Samhällsbyggnad (“XPartners”), a sustainability-focused technical consulting group, specialising in infrastructure, public and commercial buildings as well as environmental services.

Following Axcel’s investment, the XPartners’ group consists of nine business units employing approximately 400 people across 30 offices in Sweden, generating approximately SEK 600 million in revenue. XPartners is the first investment of Axcel Fund VII.

For more information about the transaction, please see the client’s press release.

Vinge’s team consisted primarily of Christina Kokko, Karl Klackenberg, Carl Fredrik Wachtmeister, Egil Svensson and Elsa Strandberg (M&A), Daniel Prawitz (Construction), Daniel Melander Björner and Tove Hallbäck (Employment), Mikael Ståhl, Seyran Sahin, Karl-Gustaw Tobola and Ida Redander (Financing), Alexandra Tamm (Real Estate), Tove Tullberg and Julia Löfqvist (Compliance), Lisa Hörnqvist (GDPR), Trine Osen Bergqvist, Victoria Fredén and Alva Chambert (ECR) and Emy Rydén (project assistant).

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024